Reaction
Keratosis Pilaris reporting signals
As of the last recalculation, Keratosis Pilaris appears in 249 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is VEMURAFENIB (PRR 273.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Vemurafenib | 34 | 273.7 | 274.5 |
| Dabrafenib | 8 | 32.8 | 32.8 |
| Faricimab | 3 | 31.3 | 31.3 |
| Adapalene | 5 | 2.3 | 2.3 |